Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Change in Accured Expenses (2018 - 2025)

Historic Change in Accured Expenses for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to -$4000.0.

  • Nexgel's Change in Accured Expenses rose 7894.74% to -$4000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$82000.0, marking a year-over-year decrease of 9069.77%. This contributed to the annual value of -$434000.0 for FY2024, which is 207272.73% down from last year.
  • As of Q3 2025, Nexgel's Change in Accured Expenses stood at -$4000.0, which was up 7894.74% from $200000.0 recorded in Q2 2025.
  • In the past 5 years, Nexgel's Change in Accured Expenses registered a high of $200000.0 during Q2 2025, and its lowest value of -$302000.0 during Q4 2024.
  • Its 5-year average for Change in Accured Expenses is -$5611.1, with a median of -$1500.0 in 2021.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 145000.0% in 2022, then tumbled by 149444.44% in 2024.
  • Over the past 5 years, Nexgel's Change in Accured Expenses (Quarter) stood at $3000.0 in 2021, then skyrocketed by 2600.0% to $81000.0 in 2022, then rose by 9.88% to $89000.0 in 2023, then tumbled by 439.33% to -$302000.0 in 2024, then skyrocketed by 98.68% to -$4000.0 in 2025.
  • Its Change in Accured Expenses was -$4000.0 in Q3 2025, compared to $200000.0 in Q2 2025 and $24000.0 in Q1 2025.